Table of Contents Table of Contents
Previous Page  144 / 398 Next Page
Information
Show Menu
Previous Page 144 / 398 Next Page
Page Background

139

CD19+IL-10+ regulatory B cells affect survival of tongue

squamous cell carcinoma patients and induce resting CD4+

T cells to CD4+Foxp3+ regulatory T cells

X. Zhou

∗

, X.M. Lao, Y.J. Liang, G.Q. Liao

Department of Oral and Maxillofacial Surgery, Guanghua

School of Stomatology, Guangdong Provincial Key Laboratory,

Sun Yat-sen University, Guangzhou, China

Objectives:

Increase of regulatory T cells (Tregs) in the tumour

microenvironment predicts worse survival of patients with vari-

ous types of cancer including tongue squamous cell carcinoma

(TSCC). Recently, the cross-talk between Tregs and regulatory B

cells (Bregs) has been shown in several tumour models. However

the relevance of Bregs to tumour immunity in humans remains elu-

sive. Our objective was to investigate the distribution and function

of Bregs in TSCC microenvironment.

Methods:

Double staining (Bregs: IL10/CD19 and Tregs:

Foxp3/CD4) was performed on tissue sections of 46 TSCC, 20

metastasis lymph nodes, and tumour adjacent normal tissue. Flow

cytometry analysis was used to detect the Bregs from magnetic

bead-sorted B cells after co-culture with TSCC cell lines, and

Tregs from sorted CD4 + CD25-T cells after co-culture with stim-

ulated B cells.

Results:

The immunohistochemical results showed that the fre-

quency of Bregs/CD19+ B in TSCC (0.80%

±

0.08%) was

significantly higher than adjacent normal tissue (0.52%

±

0.04%;

P

< 0.01). And the increase of Bregs in TSCC microenvironment

was related to Tregs and predicts worse survival in patients. Cyto-

logical experiments indicated that frequency of Bregs increased

after co-culture with TSCC cell line and that the induced B cells

converted CD4 + CD25-T cells into Tregs.

Conclusion:

The increased expression of Bregs in the TSCC

microenvironment plays a significant role in the differentiation

of resting CD4 + T cells and influenced the prognosis of TSCC

patients.

http://dx.doi.org/10.1016/j.ijom.2017.02.481

L

ong non-coding RNA UCA1 increases chemoresistance of

tongue cancer cells by regulating autophagy signaling

B. Zhou

∗

, X.M. Zhuang, Y.Y. Wang, Z.Y. Lin, D.M. Zhang,

S. Fan, Z.Q. Huang, J.S. Li, W.L. Chen

Department of Oral and Maxillofacial Surgery, Sun Yat-sen

Memorial Hospital, Sun Yat-sen University, Guangzhou, China

Background:

Intrinsic and acquired resistance to cisplatin is a big

challenge for cancer treatment. Long non-coding RNA (lncRNA)

and cytoprotective autophagy have been suggested as a potential

mechanism for chemoresistance. However, whether lncRNA regu-

late autophagy and induce cisplatin-resistance in tongue squamous

cell carcinomas (TSCCs) remains obscure.

Methods:

We used two TSCC cell lines and matched cisplatin-

resistant cell as a cell model to study autophagic flux, cisplatin

sensitivity

in vitro

, and used nude mice xenografts model to eval-

uate proliferation of TSCC cells. Finally, we evaluated the level

of UCA1 and ATG7 expression in TSCC clinical samples.

Findings:

Cisplatin induces autophagic flux in cisplatin-resistant

TSCC cells. A serial chemoresistance or tongue related lncR-

NAs were detected between cisplatin-resistant cells and parental

cells, and found that UCA1 was dramatically increased in the

cisplatin-resistant cells, as well as TSCC cells treated with cis-

platin. UCA1 knockdown sensitised cisplatin-resistant TSCC

cells, enhancing cisplatin-induced apoptosis and inhibition of

proliferation. Furthermore, UCA1 knockdown inhibited cisplatin-

induced autophagy in cisplatin-resistant cells, decreased tumour

growth response to cisplatin in mouse subcutaneous xenograft

tumour model. A serial autophagy related proteins were further

examined and identified that ATG7 was correlatively relevant to

UCA1. ATG7 knockdown inhibited basal autophagy and pro-

moted cisplatin-induced inhibition of cell proliferation and cell

death. Both UCA1 and ATG7 levels were significantly higher in

TSCC tissues and correlated with poor patient prognosis.

Conclusion:

Inhibition of UCA1 and ATG7 may be a useful ther-

apeutic strategy to overcome cisplatin-resistance by preventing

cytoprotective autophagy in tongue cancer.

http://dx.doi.org/10.1016/j.ijom.2017.02.482

Expression pattern of dickkopf WNT signaling pathway

inhibitor 3 in the malignant progression of oral submucous

fibrosis

S.H. Zhou

∗

, Y. Zhu, M. Mashrah, X.Y. Zhang, Z.J. He,

Z.G. Yao, C.Y. Zhang, F. Guo, Y.J. Hu, C.P. Zhang

Department of Oral and Maxillofacial – Head and Neck

Oncology, Shanghai Ninth People’s Hospital, Shanghai Jiao

Tong University School of Medicine, Shanghai, China

Background:

Oral squamous cell carcinoma (OSCC) is a com-

mon malignant neoplasm of head and neck. Oral submucous

fibrosis (OSF) is one of its pre-cancerous lesions, however, the key

molecular events in OSF tumourigenesis remain elusive. As one of

the Wnt antagonists, dickkopf WNT signalling pathway inhibitor

3 (DKK3) downregulation and methylation have been reported

in multiple malignancies, while no report of its expression in the

carcinogenesis of OSF.

Objectives:

The purpose of this study was to investigate DKK3

expression in normal oral, OSF and OSCC tissues, and to pre-

liminarily clarify the function of DKK3 in the carcinogenesis of

OSF.

Methods:

DKK3 expression at protein level andmRNA level were

examined by immunochemistry staining and semi-quantitative

reverse transcriptase-polymerase chain reaction in normal oral,

OSF andOSCC tissues. Geneticmutation and co-expression genes

of DKK3 in OSCC were analysed using online database.

Findings:

We found that DKK3 was readily expressed in normal

oral mucous tissues, but gradually increased in OSF early, mod-

erately advanced and advanced tissues, and strongly expressed in

OSCC tissues. DKK3 is localised in the cytoplasm in OSF pro-

gression. Raremutation of DKK3was observed inOSCC, together

with increased copy numbers. Furthermore, through analysis of

its co-expressed genes, DDK3 may deregulate Wnt signalling

pathway, p53 signalling pathway, apoptosis pathway, Ca2+ sig-

nalling pathway and mitochondrial signalling pathway in OSCC

pathogenesis.

Conclusion:

Our results demonstrate that DKK3 is upregulated

in the carcinogenesis of OSF, due to gain of copy number, which

could be a potential tumour marker for OSCC early detection.

http://dx.doi.org/10.1016/j.ijom.2017.02.483